Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
06/02/2024 | 01h53 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
01/02/2024 | 06h15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
01/02/2024 | 06h15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
01/02/2024 | 06h15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
01/02/2024 | 06h15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
01/02/2024 | 06h15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
26/01/2024 | 23h28 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
26/01/2024 | 23h28 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
26/01/2024 | 23h28 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
26/01/2024 | 23h27 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
26/01/2024 | 23h27 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
26/01/2024 | 23h27 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
26/01/2024 | 23h27 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
26/01/2024 | 23h27 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
26/01/2024 | 23h27 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
26/01/2024 | 23h27 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
26/01/2024 | 23h26 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
26/01/2024 | 23h26 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
26/01/2024 | 23h26 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
26/01/2024 | 23h26 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
26/01/2024 | 23h26 | Edgar (US Regulatory) | Form 15-12G - Securities registration termination [Section 12(g)] | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
26/01/2024 | 23h26 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
16/01/2024 | 19h53 | Edgar (US Regulatory) | Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
21/11/2023 | 00h43 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
21/11/2023 | 00h10 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
13/11/2023 | 20h58 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
16/05/2014 | 15h47 | Dow Jones News | U.S. Hot Stocks: Hot Stocks to Watch | AMEX:NAVB | Navidea Biopharmaceuticals Inc. |
18/02/2014 | 15h18 | Dow Jones News | U.S. Hot Stocks: Hot Stocks to Watch | AMEX:NAVB | Navidea Biopharmaceuticals Inc. |
10/12/2013 | 15h33 | Dow Jones News | U.S. Hot Stocks Futures: Hot Stocks to Watch | AMEX:NAVB | Navidea Biopharmaceuticals Inc. |
24/04/2013 | 15h36 | Dow Jones News | Navidea Sells More Shares to J.P. Morgan's Asset Management Unit and Another Institutional Investor | AMEX:NAVB | Navidea Biopharmaceuticals Inc. |